verified SJR 0,343 · Q3 • database Scopus / SJR indexed

United States · Current Science, Inc.

workspace_premium Q3 — Cardiology and Cardiovascular Medicine lock_open Open Access

Current Treatment Options in Cardiovascular Medicine

Current Treatment Options in Cardiovascular Medicine is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 42. It has a price of 2590 €. It has an SJR impact factor of 0,343 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,343.

ISSN: 1092-8464

Publisher: Current Science, Inc.

Category: Cardiology and Cardiovascular Medicine

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,343 Q3

H-index 42

Acceptance rate pie_chart

35%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.590 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,343

H-index

Docs (year)

Docs 3y

144

Total refs

1890

Cites 3y

119

Citable 3y

144

Cites/Doc 2y

0.67

Ref/Doc

70.0

Immediate OA

2590 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiac MRI in the management of congenital heart disease in children, adolescents, and young adults

Why Do Some Recovered Peripartum Cardiomyopathy Mothers Experience Heart Failure With a Subsequent Pregnancy?

CT Imaging of the Vulnerable Plaque

Coronary Revascularization in Cardiogenic Shock

Coronary Angiography and Revascularization Prior to Noncardiac Surgery

Controversies in Cardioembolic Stroke

Combination Aspirin and Clopidogrel for Secondary Prevention of Ischemic Stroke

Chemotherapy and QT Prolongation: Overview With Clinical Perspective

Cervical artery dissection

Care of the adult with congenital heart disease

Cardiovascular Evaluation of Children With Malignancies

Cardiovascular dysfunction in sepsis and septic shock

SHOW MORE ARTICLES

Cardiac resynchronization therapy

A Review of Alternative Access for Transcatheter Aortic Valve Replacement

Breast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology

Biliary and gallbladder dyskinesia

Autonomic Regulation and Ventricular Arrhythmias

Autonomic Dysregulation as a Therapeutic Target for Acute HF

Assessment of the QT Interval in Athletes: Red Flags and Pitfalls

Assessment of Mitral Valve Disease: A Review of Imaging Modalities

Arterial Thrombosis in Patients with Cancer

Approach to Venous Thromboembolism in the Cancer Patient

Advances in the management of gastroparesis

Advances in Management of Stable Coronary Artery Disease: the Role of Revascularization?

FAQs

Current Treatment Options in Cardiovascular Medicine has an SJR of 0,343 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2590 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Treatment Options in Cardiovascular Medicine is 35%.

Current Treatment Options in Cardiovascular Medicine

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Treatment Options in Cardiovascular Medicine?

What is the APC / publication cost?

What is the acceptance rate?